NO20001680D0 - Nucleic acids that encode proteins capable of interacting with presenilines - Google Patents

Nucleic acids that encode proteins capable of interacting with presenilines

Info

Publication number
NO20001680D0
NO20001680D0 NO20001680A NO20001680A NO20001680D0 NO 20001680 D0 NO20001680 D0 NO 20001680D0 NO 20001680 A NO20001680 A NO 20001680A NO 20001680 A NO20001680 A NO 20001680A NO 20001680 D0 NO20001680 D0 NO 20001680D0
Authority
NO
Norway
Prior art keywords
presenilines
interacting
nucleic acids
encode proteins
proteins capable
Prior art date
Application number
NO20001680A
Other languages
Norwegian (no)
Other versions
NO20001680L (en
Inventor
Alain Fournier
Luc Mercken
Laurent Pradier
Marie-Francoise Paul
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9712221A external-priority patent/FR2769021B1/en
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of NO20001680D0 publication Critical patent/NO20001680D0/en
Publication of NO20001680L publication Critical patent/NO20001680L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/11DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711Alzheimer's disease; Amyloid plaque core protein
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00Uses of viruses
    • C12N2799/02Uses of viruses as vector
    • C12N2799/021Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Psychiatry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO20001680A 1997-10-01 2000-03-31 Nucleic acids that encode proteins capable of interacting with presenilines NO20001680L (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9712221A FR2769021B1 (en) 1997-10-01 1997-10-01 NUCLEIC ACIDS ENCODING PROTEINS CAPABLE OF INTERACTING WITH PRESENILINS
US9493398P 1998-07-31 1998-07-31
PCT/FR1998/002093 WO1999016874A1 (en) 1997-10-01 1998-09-30 Nucleic acids coding for proteins capable of interacting with presenilins

Publications (2)

Publication Number Publication Date
NO20001680D0 true NO20001680D0 (en) 2000-03-31
NO20001680L NO20001680L (en) 2000-03-31

Family

ID=26233829

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001680A NO20001680L (en) 1997-10-01 2000-03-31 Nucleic acids that encode proteins capable of interacting with presenilines

Country Status (10)

Country Link
EP (1) EP1021533A1 (en)
JP (1) JP2001518294A (en)
KR (1) KR20010030862A (en)
CN (1) CN1272139A (en)
AU (1) AU9354998A (en)
CA (1) CA2305781A1 (en)
HU (1) HUP0004739A3 (en)
IL (1) IL135187A0 (en)
NO (1) NO20001680L (en)
WO (1) WO1999016874A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001066745A2 (en) * 2000-03-03 2001-09-13 The Salk Institute For Biological Studies Presenilin/crk binding polypeptides (pcbp) and methods of use thereof
CA2458207A1 (en) * 2001-05-03 2002-11-14 Murdoch Childrens Research Institute Determination of a genetic predisposition for behavioural disorders
JP2003012548A (en) * 2001-06-27 2003-01-15 Japan Science & Technology Corp Medicine composition
JP2003018991A (en) * 2001-06-27 2003-01-21 Japan Science & Technology Corp Nucleic acid relating to formation of splicing disorder defective in exon 5 of presenilin-2 gene
CN102206252A (en) * 2010-10-25 2011-10-05 深圳华大基因科技有限公司 Presenilin-5 inhibitive factor antigen epitope, anti-presenilin-5 inhibitive factor antibody and purpose thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000506375A (en) * 1996-01-26 2000-05-30 エイチエスシー リサーチ アンド デベロップメント リミテッド パートナーシップ Nucleic acids and proteins associated with Alzheimer's disease and uses thereof

Also Published As

Publication number Publication date
CN1272139A (en) 2000-11-01
IL135187A0 (en) 2001-05-20
NO20001680L (en) 2000-03-31
HUP0004739A1 (en) 2001-05-28
HUP0004739A3 (en) 2003-10-28
WO1999016874A1 (en) 1999-04-08
JP2001518294A (en) 2001-10-16
EP1021533A1 (en) 2000-07-26
AU9354998A (en) 1999-04-23
KR20010030862A (en) 2001-04-16
CA2305781A1 (en) 1999-04-08

Similar Documents

Publication Publication Date Title
DE69822216D1 (en) MULTIPLE SYRINGE FOR MANUAL APPLICATION OF SUBSTANCES
NO990123D0 (en) Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
NO20011574L (en) Substituted 3-cyanoquinolines as protein tyrosine kinase inhibitors
DK0927192T3 (en) Modified amino acids, drugs containing these compounds and methods for their preparation
ATE546139T1 (en) ISOPRENT TRANSFERASE PROTEINS INHIBITORS
DK2270234T3 (en) Method for Preparation of Polynucleotide and Polypeptide Sequences
DE69739128D1 (en) Invasive cleavage of nucleic acids
DK1047694T3 (en) Bicyclic heteroaromatic compounds as protein tyrosine kinase inhibitors
DK1035771T3 (en) Surfactant for liquid aqueous preparations
NO20001748L (en) Method for Modulating Serine / Threonine Protein Kinase Function with 5-Azaquinoxaline-Based Compounds
DK0806474T3 (en) Method of stabilizing beverages
DK0885566T3 (en) Solvent with cream-like properties for beverages
IS2261B (en) Process for the preparation of 5-cyanothalide
NO20010362D0 (en) Nucleic acids encoding proteins involved in sensory transduction
DK1034173T3 (en) Process for the preparation of 8-methoxy-quinolone carboxylic acids
DE59813668D1 (en) Process for the preparation of frozen LPG
DE69922740D1 (en) Method for the separation of nucleic acids by liquid chromatography
DE69808104D1 (en) SYSTEM FOR CONTROLLING THE OUTPUT OF ELECTRICALLY CONDUCTIVE LIQUID
NO20001680L (en) Nucleic acids that encode proteins capable of interacting with presenilines
DK0925273T3 (en) Pharmaceutical preparations containing 4-oxo-butanoic acids
DK0864564T3 (en) Particular method for the preparation of alpha-bromolactam derivatives
FI962044A0 (en) DNA sequences encoding carboxypeptidase B in the pancreas of pigs
DE29722473U1 (en) Separation device for the separation of substances
NO20021614L (en) DNA encoding PROST 07 polypeptide
NO20002321D0 (en) Biphenyl derivatives as pharmaceutical agents